LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q1 EPS of $0.04, $0.03 better than the analyst estimate of $0.01. Revenue for the quarter came in at $403.48 million versus the consensus estimate of $387.43 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2026 revenue of $1.64-1.68 billion, versus the consensus of $1.63 billion.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.